CompanyHealthHardware
Orca Bio
Orca Bio is a late-stage biotechnology company in Menlo Park, California, building high-precision allogeneic cell therapies. Its proprietary single-cell sorting platform purifies donor immune and stem cells to engineer optimized therapeutic mixtures aimed at curing blood cancers and autoimmune diseases, with its lead candidate Orca-T currently under FDA priority review.
2016Founded
Menlo ParkHQ
$250M aggregate plus up to $100M credit facilitySeries F
cell therapyprecision medicineallogeneicblood cancerleukemiabiotech